News

Deal Announcements

Helix Therapeutics Raises Venture Capital Financing

Monday, March 9, 2009 5:38:00 AM PDT | VentureDeal Staff
New Haven, Connecticut  --  DNA technology company Helix Therapeutics has raised $965,000 in a round of venture capital funding.

Helix is developing DNA-based therapeutics that it says will "cause a paradigm shift in the way that common genetic diseases are treated, by permanently curing them."

Investors in the round included Connecticut Innovations, Launch Capital and other undisclosed investors. The company did not disclose how the funding proceeds would be used.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1